Skip to main content
Journal cover image

What have we learned from the REPRIEVE trial and where do we go from here?

Publication ,  Journal Article
Grinspoon, SK; Lu, MT; Zanni, MV; Diggs, MR; Chu, SM; Ribaudo, HJ; Douglas, PS
Published in: HIV Med
December 2024

Duke Scholars

Published In

HIV Med

DOI

EISSN

1468-1293

Publication Date

December 2024

Volume

25

Issue

12

Start / End Page

1283 / 1288

Location

England

Related Subject Headings

  • Virology
  • 4202 Epidemiology
  • 3202 Clinical sciences
  • 1103 Clinical Sciences
 

Citation

APA
Chicago
ICMJE
MLA
NLM
Grinspoon, S. K., Lu, M. T., Zanni, M. V., Diggs, M. R., Chu, S. M., Ribaudo, H. J., & Douglas, P. S. (2024). What have we learned from the REPRIEVE trial and where do we go from here? HIV Med, 25(12), 1283–1288. https://doi.org/10.1111/hiv.13703
Grinspoon, Steven K., Michael T. Lu, Markella V. Zanni, Marissa R. Diggs, Sarah M. Chu, Heather J. Ribaudo, and Pamela S. Douglas. “What have we learned from the REPRIEVE trial and where do we go from here?HIV Med 25, no. 12 (December 2024): 1283–88. https://doi.org/10.1111/hiv.13703.
Grinspoon SK, Lu MT, Zanni MV, Diggs MR, Chu SM, Ribaudo HJ, et al. What have we learned from the REPRIEVE trial and where do we go from here? HIV Med. 2024 Dec;25(12):1283–8.
Grinspoon, Steven K., et al. “What have we learned from the REPRIEVE trial and where do we go from here?HIV Med, vol. 25, no. 12, Dec. 2024, pp. 1283–88. Pubmed, doi:10.1111/hiv.13703.
Grinspoon SK, Lu MT, Zanni MV, Diggs MR, Chu SM, Ribaudo HJ, Douglas PS. What have we learned from the REPRIEVE trial and where do we go from here? HIV Med. 2024 Dec;25(12):1283–1288.
Journal cover image

Published In

HIV Med

DOI

EISSN

1468-1293

Publication Date

December 2024

Volume

25

Issue

12

Start / End Page

1283 / 1288

Location

England

Related Subject Headings

  • Virology
  • 4202 Epidemiology
  • 3202 Clinical sciences
  • 1103 Clinical Sciences